Biological Technologies

US · VA DARPA - Biological Technologies Office (BTO) grant open #HR001126S0003

Response due Sep 30, 2026 · 00:00 UTC

Summary

DARPA's Biological Technologies Office (BTO) is soliciting proposals under a broad agency announcement (synopsis) for biological technologies research and development. The opportunity is open for a full fiscal year (October 2025 through September 2026), consistent with BTO's standing open BAA model for accepting innovative proposals across its portfolio. Specific program areas, technical requirements, and evaluation criteria are expected to be detailed in the full solicitation document. This is a federal R&D funding opportunity posted on Grants.gov.

What they want

Open-period synopsis solicitation from DARPA's Biological Technologies Office (BTO) for research, development, and related activities in the domain of biological technologies. The solicitation is active for the full federal fiscal year 2026 (October 1, 2025 – September 30, 2026). Full technical scope, program areas, deliverables, and award terms are expected to be contained in the referenced solicitation document HR001126S0003.

How they evaluate

Submission: Grants.gov portal (electronic submission)

Risks & flags

Solicitation text is extremely sparse — only metadata is provided; no scope details, evaluation criteria, or technical requirements are available to assess competitive fairness
Year-long open window is typical of DARPA BAAs but may mask targeted program calls issued as addenda

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541714

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Biological Technologies

Due Sep 30

Onboard ↗